Rhodes Jason P (CIK 1577014) reported 65 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-08). Recent activity: Sell DYN (253,039 shares), Sell DYN (127,182 shares), Sell DYN (100,019 shares), Sell DYN (124,379 shares), Sell DYN (29,587 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 253,039 | $5.8M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 127,182 | $2.9M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 100,019 | $2.3M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 124,379 | $2.9M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 29,587 | $698,845 |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 62,543 | $1.4M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 14,844 | $350,615 |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 49,193 | $1.1M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 11,665 | $275,527 |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 5,000 | $118,050 |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 64,411 | $1.4M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 81,903 | $1.7M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 162,954 | $3.5M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 102,969 | $2.2M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 51,756 | $1.1M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 40,702 | $860,440 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 77,855 | $1.6M |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 39,131 | $826,838 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 30,774 | $650,255 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 50,530 | $1.1M |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 25,397 | $533,845 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 19,973 | $419,832 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 12,699 | $267,949 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 6,382 | $134,660 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 5,019 | $105,901 |
Source: SEC Form 4 filings · as of 2026-07-08